Does LISOCABTAGENE MARALEUCEL Cause Muscular weakness? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Muscular weakness have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 0.8% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
6
Reports of Muscular weakness with LISOCABTAGENE MARALEUCEL
0.8%
of all LISOCABTAGENE MARALEUCEL reports
0
Deaths
6
Hospitalizations
How Dangerous Is Muscular weakness From LISOCABTAGENE MARALEUCEL?
Of the 6 reports, 6 (100.0%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
Yes, Muscular weakness is listed as a known adverse reaction in the official FDA drug label for LISOCABTAGENE MARALEUCEL.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Neurotoxicity (101)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Lymphocyte adoptive therapy (25)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Muscular weakness Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE